Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells.
Justin T HuckabyElisa LandoniTimothy M JacobsBarbara SavoldoGianpietro DottiSamuel K LaiPublished in: Journal for immunotherapy of cancer (2022)
These findings underscore in vivo engineering of CAR-T cells as a promising approach for personalized cancer immunotherapy.
Keyphrases